Form D · Biotechnology
Bambino Topco Inc.
Amsterdam, P7 · CIK 0001719235
Offering snapshot reported Nov 4, 2019 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 4, 2019 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Nov 7, 2018 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Nov 8, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 12, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-298277
Source: Form D, filed Nov 4, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sofia Hasni Ahuja | Executive |
| Martha Aronson | Director |
| Isabelle Billet | Director |
| Bill Enquist | Director |
| Jerry He | Director |
| Amit Kakar | Director |
| Adam Larsson | Executive |
| John Ma | Director |
| Ken Reali | Director |
| Brendan Scollans | Director |
| Marie Louise Van Dam | Executive |
| Peter Veldman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Cornelis Schuytstraat 74
Amsterdam, P7, 1071 JL
Amsterdam, P7, 1071 JL